Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 28 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,991.20
Market cap: ₹4,658 Cr
Revenue (annual): ₹505.9 Cr
Net profit (annual): ₹42.05 Cr
P/E (TTM): 90.7×Sector 36.8×
Promoter holding: 72.02%+0.00% QoQ
FII holding: 3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 3 Annual General Meeting 3 Other Announcement 2 Management Change 2 Debt & Borrowing 2 Capacity Expansion 2 Board Meeting Date 2 Dividend 1 Credit Rating 1 Business Update 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Sep 2026 17:16 IST NSE

Credit Rating

Tatva Chintan Pharma Chem Credit Rating

CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.

Read the filing ↗